The Faculty of Medicine: Innovation Changing Lives
At the Hebrew University’s Faculty of Medicine, Israel’s most brilliant medical and scientific minds are working together to unlock the mysteries of the genes and proteins that control fundamental processes in living cells. They are creating treatments and drug therapies to ameliorate and prevent disease, training the next generation of compassionate medical specialists, and sharing knowledge with students from around the world.
Visit Dr. Amir Amedi of the Hebrew University’s Edmond and Lily Safra Center for Brain Sciences (ELSC) and Institute for Medical Research Israel-Canada (IMRIC) in his lab and see how he and his team are actively helping blind people function better in daily life while also studying how brain plasticity can be harnessed to help them even further.
In an innovative research approach to understanding risk factors for type 2 diabetes, a research team led by the Hebrew University’s Institute for Medical Research Israel-Canada (IMRIC) mapped DNA methylation variations rather than the traditional DNA sequence variations. The results revealed an early-warning signal that could lead to new therapeutic approaches for this and other human diseases.
Using their insight that fatal bacterial toxins, or superantigens, rely on binding to a specific protein in order to wreak damage, a team of Hebrew University researchers has designed protein decoys that prevent the immune system from going into overdrive in reaction to a superantigen attack. Their findings provide a novel therapeutic approach against toxic shock.
In identifying the key signal that triggers beta cell regeneration, Hebrew University researchers have made a breakthrough discovery that may ultimately lead to finding a full cure for type 1 diabetes. The research team’s study was the first time that the sensing of a high level of glucose has been shown to be the “trigger” that induces beta cells to regenerate.